Disease aging clocks in the plasma proteome stratify risk and track preclinical progression
Year: 2026
Type: preprint
Abstract: Aging is the strongest risk factor for most chronic diseases, yet people of the same chronological age differ in how far disease processes have advanced. Existing plasma proteomic clocks estimate chronological age, or the age of a single organ, but none targets the pathway from aging to a specific disease. Here we developed disease aging clocks by deriving the plasma proteomic composite that maximizes the age-mediated component of disease risk and applied the framework to 31 age-related diseases in 44,526 UK Biobank participants. The resulting disease age gap separated 10-year incidence up to 20-fold among individuals of the same chronological age, and each additional year of gap raised the hazard of type 2 diabetes by 24%, chronic kidney disease by 21% and Alzheimer′s disease (AD) by 17%. Among participants who went on to develop disease, the gap was larger closer to diagnosis in 19 of 20 diseases, indicating that it reports preclinical stage rather than fixed susceptibility. Across these 20 diseases, 56% of the gap was orthogonal to chronological and organ-specific clocks. Applied without refitting to Stanford Alzheimer′s Disease Research Center participants (n=501), the AD clock was elevated in AD and Lewy body disease but not Parkinson′s disease, and tracked plasma biomarkers, cognition and neuroimaging features. Disease aging clocks provide a blood-based measure of the stage of a specific aging-to-disease process years before diagnosis, with potential applications in prevention-trial enrichment and longitudinal disease monitoring.
Source: Research Square
Institutions: Stanford University, Stanford Medicine
Language: English
Subfield: Aging
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7226013326
